Ameriprise’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-3,360,266
| Closed | -$65.4M | – | 3768 |
|
|
2018
Q1 | $65.4M | Buy |
3,360,266
+114,445
| +4% | +$2.25M | 0.03% | 527 |
|
|
2017
Q4 | $54M | Buy |
3,245,821
+311,436
| +11% | +$5.71M | 0.02% | 556 |
|
|
2017
Q3 | $59.6M | Buy |
2,934,385
+131,572
| +5% | +$2.52M | 0.03% | 508 |
|
|
2017
Q2 | $45.1M | Sell |
2,802,813
-33,389
| -1% | -$493K | 0.02% | 590 |
|
|
2017
Q1 | $35.9M | Buy |
2,836,202
+450,233
| +19% | +$5.44M | 0.02% | 671 |
|
|
2016
Q4 | $31.6M | Buy |
2,385,969
+426,959
| +22% | +$7.3M | 0.02% | 717 |
|
|
2016
Q3 | $46.4M | Buy |
1,959,010
+958,291
| +96% | +$25.8M | 0.03% | 526 |
|
|
2016
Q2 | $28.8M | Buy |
1,000,719
+116,260
| +13% | +$3.79M | 0.02% | 721 |
|
|
2016
Q1 | $28.3M | Buy |
884,459
+186,221
| +27% | +$6.55M | 0.02% | 740 |
|
|
2015
Q4 | $29.9M | Sell |
698,238
-67,550
| -9% | -$2.7M | 0.02% | 699 |
|
|
2015
Q3 | $27M | Sell |
765,788
-120,803
| -14% | -$5.44M | 0.02% | 752 |
|
|
2015
Q2 | $40.7M | Sell |
886,591
-334,037
| -27% | -$15.9M | 0.02% | 606 |
|
|
2015
Q1 | $57.2M | Sell |
1,220,628
-376,008
| -24% | -$15M | 0.03% | 480 |
|
|
2014
Q4 | $50.6M | Buy |
1,596,636
+51,865
| +3% | +$1.52M | 0.03% | 514 |
|
|
2014
Q3 | $36.6M | Sell |
1,544,771
-29,779
| -2% | -$763K | 0.02% | 628 |
|
|
2014
Q2 | $47.2M | Sell |
1,574,550
-57,817
| -4% | -$1.56M | 0.03% | 563 |
|
|
2014
Q1 | $43.1M | Buy |
1,632,367
+12,779
| +0.8% | +$319K | 0.03% | 600 |
|
|
2013
Q4 | $40.7M | Sell |
1,619,588
-469,167
| -22% | -$10.5M | 0.02% | 619 |
|
|
2013
Q3 | $42.8M | Sell |
2,088,755
-186,227
| -8% | -$3.85M | 0.03% | 595 |
|
|
2013
Q2 | $45.4M | Buy |
+2,274,982
| New | +$40.4M | 0.03% | 553 |
|
Ameriprise's IPXL Position: Q2 2018 in Review
Ameriprise sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 3,360,266 shares — an estimated $65.4M sold.
Ameriprise first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $65.4M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Ameriprise reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Ameriprise sold 3,360,266 Impax Laboratories, Inc. shares in Q2 2018, an estimated $65.4M.
- Ameriprise first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Ameriprise's Impax Laboratories, Inc. position peaked at $65.4M in Q1 2018.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Ameriprise's 13F filing for Q2 2018, filed 14 Aug 2018.